Exocure
PrivateTotal Funding Raised
$1.1M
Company Overview
Exocure is a biotechnology company that develops exosome-based delivery platforms for targeted drug delivery and therapeutic solutions for cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
exosome therapeuticsdrug delivery platformexosome engineeringtargeted drug deliverybioprocessing technologyimmuno-oncologysynthetic vesiclesbiotech R&Dexosome isolationnanomedicinecargo loadingbiotech licensingcell targetingnext-gen biologics
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exocure Comparables
Compare Exocure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 84% | |
| SHIFTBIO | 84% | |
| Vesigen Therapeutics | 83% | |
Exocure Funding Rounds
Historical fundraising activity
Exocure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | VC Round |
Exocure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exocure's valuation, stock price, and market status.
See something wrong or outdated?